Lack of antigenicity of recombinant human thyrotropin after multiple injections in patients with differentiated thyroid cancer

被引：6
|
作者：
Paterakis, T [1 ]
Ebels, H
Mallick, UK
Proud, G
Jones, N
Lucraft, H
Fenwick, J
Weightman, D
Kendall-Taylor, P
Perros, P
机构：
[1] Freeman Rd Hosp, NE England Thyroid Canc Grp, Med Unit 3, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England
[2] Genzyme BV, Naarden, Netherlands
来源：
THYROID | 2000年 / 10卷 / 07期
关键词：
D O I：
10.1089/thy.2000.10.623
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：623 / 623
页数：1
相关论文
共 50 条
  • [1] THE ROLE OF RECOMBINANT HUMAN THYROTROPIN FOR DIAGNOSTIC MONITORING OF PATIENTS WITH DIFFERENTIATED THYROID CANCER
    Sherman, Steven I.
    [J]. ENDOCRINE PRACTICE, 2013, 19 (01) : 157 - 161
  • [2] Recombinant human thyrotropin (TSH) in the management of patients with differentiated thyroid cancer.
    McDougall, IR
    Weigel, RJ
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05): : 323P - 323P
  • [3] Recombinant human thyrotropin in follow-up of patients with differentiated thyroid cancer
    Podoba, J.
    [J]. BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2010, 111 (01): : 38 - 40
  • [4] Recombinant human thyrotropin (rhTSH) in the management of differentiated thyroid cancer
    Durski, JM
    Weigel, RJ
    McDougall, IR
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2000, 21 (06) : 521 - 528
  • [5] Recombinant human thyrotropin in evaluating patients with differentiated thyroid carcinoma
    Podoba, Jan
    [J]. ENDOCRINE JOURNAL, 2010, 57 : S456 - S456
  • [6] The use of Recombinant Human Thyrotropin (rhTSH) in the Management of Differentiated Thyroid Cancer
    Skarulis M.C.
    [J]. Reviews in Endocrine and Metabolic Disorders, 2000, 1 (3) : 147 - 154
  • [7] Radioiodine Thyroid Remnant Ablation after Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal in Patients with High-Risk Differentiated Thyroid Cancer
    Pitoia, Fabian
    Marlowe, Robert J.
    Abelleira, Erika
    Faure, Eduardo N.
    Bueno, Fernanda
    Schwarzstein, Diego
    Julio Lutfi, Ruben
    Niepomniszcze, Hugo
    [J]. JOURNAL OF THYROID RESEARCH, 2012, 2012
  • [8] POTENTIAL USE OF RECOMBINANT HUMAN THYROTROPIN IN THE TREATMENT OF DISTANT METASTASES IN PATIENTS WITH DIFFERENTIATED THYROID CANCER
    Klubo-Gwiezdzinska, Joanna
    Burman, Kenneth D.
    Van Nostrand, Douglas
    Mete, Mihriye
    Jonklaas, Jacqueline
    Wartofsky, Leonard
    [J]. ENDOCRINE PRACTICE, 2013, 19 (01) : 139 - 148
  • [9] Cardiovascular safety of acute recombinant human thyrotropin administration to patients monitored for differentiated thyroid cancer
    Biondi, B
    Palmieri, EA
    Pagano, L
    Klain, M
    Scherillo, G
    Salvatore, M
    Fenzi, G
    Lombardi, G
    Fazio, S
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (01): : 211 - 214
  • [10] The use of recombinant thyrotropin in the follow-up of patients with differentiated thyroid cancer
    Basaria, M
    Graf, H
    Cooper, DS
    [J]. AMERICAN JOURNAL OF MEDICINE, 2002, 112 (09): : 721 - 725
12345